Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Performance Equity Management (PEM) is a global private equity investment manager that manages a diverse range of portfolios, including venture capital, buyout, and special situations. Founded in 2005 as a spin-out from General Motors Investment Management Corporation (GMIMCo), the firm provides institutional investors with access to private equity through primary fund investments, secondary market purchases, and direct co-investments. While PEM is not a biotechnology company itself, it maintains a significant presence in the life sciences sector through its venture capital and growth equity investments in healthcare and medical technology firms. The firm is headquartered in Greenwich, Connecticut, and manages billions in assets for a global client base of institutional investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Performance Equity Management.